Rocket Lab's Two-Track Story: A Mature Launch Business Carries the Weight of an Unproven Heavy Lifter

Rocket Lab's record revenue and GHOST launch platform contrast with weak Q3 margin guidance, sending shares down 14% from last week.

The most revealing news out of Rocket Lab this month wasn't the billion-dollar contract, the record revenue print, or even the progress on the Iridium acquisition. It was a portable launch platform called GHOST — a system designed to make Electron and HASTE missions more flexible and location-independent, built for rapid-response and security-focused campaigns. The disclosure, reported by Ars Technica in mid-August, barely registered against the noise of the company's other headlines. But it speaks volumes about how Rocket Lab is fortifying its bread-and-butter business while the market fixates on the far bigger, far riskier question mark: Neutron.

That split personality is now the defining feature of the stock. The shares have been under pressure since the second-quarter earnings report on August 10, with the sell-off deepening through last week. The stock was changing hands at €61.30 on Monday, down 1.8 percent on the day and roughly 14 percent below the level of a week earlier. The gap to the 50-day moving average of €70.74 stands at 13 percent — a measure of just how persistent the post-earnings weakness has become.

The Operating Engine Keeps Humming

Strip away the share-price drama, and the operational picture is arguably the strongest in the company's history. The 93rd Electron mission flew over the weekend of August 20–21, carrying a QPS-SAR Earth-observation satellite for Japanese customer iQPS — the ninth such payload delivered for that client. Rocket Lab says its Electron success rate now stands at 100 percent, and the launch was the 14th of 2026, a cadence that underscores how the small-launch vehicle has matured into a dependable revenue generator rather than a speculative venture.

The satellite-manufacturing side is advancing too. Eight of 17 spacecraft platforms from a $143 million contract with MDA Space for the Globalstar constellation are now in orbit, a milestone announced on August 16. The company is clearly being taken seriously as an end-to-end space systems supplier, not merely a ride provider.

That positioning was reinforced by a fresh wave of government work. Viasat selected Rocket Lab to build a geostationary satellite bus under the US Space Force's Protected Tactical SATCOM-Global program. The company was also admitted to the Space Data Network Consortium, securing $12 million in orders for a global military communications network. And the headline grabber: selection for the $981 million NITE-STAR program, which develops war-gaming and training architectures for the military.

What Actually Broke the Momentum

The proximate cause of the share-price slide, however, lies in the August 10 earnings report. Revenue came in at $234 million, up 62 percent year over year — a record. But the bottom line missed: the per-share loss of $0.08 was wider than the $0.06 analysts had penciled in. More damaging was the third-quarter gross margin guidance of 29 to 31 percent, well short of the 37.6 percent consensus. That shortfall, more than anything else, reset expectations.

Compounding the margin disappointment is the dilution overhang tied to the Iridium acquisition. On August 13, Rocket Lab struck a deal with Deutsche Bank and Wells Fargo allowing for at-market equity sales of up to $1.944 billion to fund the multibillion-dollar takeover. The antitrust review cleared the HSR waiting period on August 12, and the company subsequently filed its S-4 registration with the SEC — regulatory milestones that keep the deal on track but do little to ease investor concerns about share count.

The Neutron Question Won't Go Away

Then there is Neutron, the medium-lift rocket that represents both the company's biggest upside and its most persistent source of anxiety. Management reaffirmed on August 10 that production remains on track for delivery to the launch pad in the fourth quarter of 2026. But Reuters reported that the company has dialed back its confidence in a first flight this year, and Bloomberg went further, flagging a slip into 2027 as a real possibility.

The market is clearly pricing in that risk. The stock closed Friday at €62.40, roughly flat on the day but 12 percent below the prior week's level. It sits 13 percent beneath the 50-day average of €71.40 and a staggering 53 percent off the 52-week high set in May. That drawdown looks less like a fundamental breakdown than a repricing of Neutron's timing risk — a reassessment that has been written directly into the chart.

Notably, customers still appear to believe in the vehicle. Kepler Communications has booked a dedicated Neutron mission from Wallops Island, with a launch date no earlier than 2028. The long lead time cuts both ways: it shows commercial confidence in the rocket, but it also means the revenue contribution is years away.

Analysts See Upside, With Caveats

Wall Street's response to the earnings turbulence has been measured but broadly constructive. Cantor Fitzgerald raised its price target to $122 from $96 on August 11, maintaining an "Overweight" rating. Citizens JMP reaffirmed a $130 target with a "Market Outperform" call the same day. Roth Capital set its target at $110. The spread of those numbers suggests that even with the margin guidance disappointment, established houses continue to see substantial upside from current levels.

The near-term path, though, hinges on how the market weighs two very different businesses. The Electron franchise is delivering with mechanical reliability, the Iridium integration is clearing its regulatory hurdles, and GHOST demonstrates that management is actively evolving the launch business rather than waiting passively for Neutron to save the day. The diversification strategy is real, and it's working.

But the delay debate around the heavy-lift vehicle remains the swing factor keeping a lid on the stock. Investors who believe Rocket Lab's diversified model can carry the valuation even without a punctual Neutron debut may well view the current weakness as a pause rather than a turning point. Those who see Neutron as the primary driver of the multiple will have to sit with the uncertainty at least until the fourth quarter. The operational substance is there — the question is whether the market's patience will hold out until the next Neutron update arrives.